, Volume 31, Issue 3, pp 142–145 | Cite as

Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion

  • T. Jensen
  • S. Stender
  • T. Deckert


Type 1 (insulin-dependent) diabetic patients with clinical nephropathy have a more than ten-fold increase in mortality of cardiovascular diseases compared with diabetic patients without nephropathy. The risk factors for cardiovascular disease, plasma concentrations of lipoproteins and fibrinogen, were investigated in 74 long-term diabetic patients: 37 with normal urinary albumin excretion, 20 with incipient nephropathy and 17 with overt clinical nephropathy based on urinary albumin excretion. The groups were matched according to sex, age and diabetes duration. The concentration of plasma cholesterol, very low density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride and fibrinogen rose with increasing urinary albumin excretion. The plasma concentrations of these lipoproteins and fibrinogen were 11–14% higher in the patients with incipient nephropathy and 26–87% higher in the patients with overt clinical ne phropathy compared with the patients without nephropathy. The plasma concentration of high density lipoprotein cholesterol was unaffected by albuminuria. Patients with normal urinary albumin excretion and HbA1c>8.0% had significantly higher very low density lipoprotein- and lower high density lipoprotein cholesterol concentrations compared with patients with HbA1c<8.0%. Simple addition of the described risk factors can only account for a minor part of the greatly increased cardiovascular mortality in patients with diabetic nephropathy. An additional and possibly more decisive factor might be a change in the arterial wall, a change which promotes lipid accumulation and/or facilitates thrombus formation.

Key words

Type 1 (insulin-dependent) diabetes urinary albumin excretion lipoproteins fibrinogen metabolic control 


  1. 1.
    Borch-Johnsen K, Kragh Andersen P, Deckert T (1985) The effect of proteinuria on relative mortality in Type I (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596Google Scholar
  2. 2.
    Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 6: 356–360Google Scholar
  3. 3.
    Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1: 17–19Google Scholar
  4. 4.
    Borch-Johnsen K, Kreiner S (1987) Proteinuria — a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294: 1651–1655Google Scholar
  5. 5.
    Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Incidence and risk factors. Diabetologia 30: 144–148Google Scholar
  6. 6.
    Christiansen JS (1978) Cigarette smoking and prevalence of microangiopathy in juvenile onset insulin-dependent diabetes mellitus. Diabetes Care 1: 146–149Google Scholar
  7. 7.
    Parving H-H, Andersen AR, Smidt UM, Oxenbøll B, Edsberg B, Sandahl Christiansen J (1983) Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10–12Google Scholar
  8. 8.
    Feldt-Rasmussen B, Borch-Johnsen K, Mathiesen ER (1985) Hypertension in diabetes as related to nephropathy. Early blood pressure changes. Hypertension 7 [Suppl 2] 1118–1120Google Scholar
  9. 9.
    Valdorf-Hansen F (1967) Coagulability in diabetics. Acta Med Scand [Suppl] 476: 147–157Google Scholar
  10. 10.
    Keiding NR, Mann GV, Root HF, Lawry EY, Marble A (1952) Serum lipoproteins and cholesterol levels in normal subjects and in young patients with diabetes in relation to vascular complications. Diabetes 1 (6): 434–440Google Scholar
  11. 11.
    Eckel RH, McLean E, Albers JJ, Cheung MC, Bierman EL (1981) Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care 4: 447–453Google Scholar
  12. 12.
    Vannini P, Clavarella A, Flammini M, Bargossi AM, Forlani G, Borgnino LC, Orsoni G (1984) Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care 7: 151–154Google Scholar
  13. 13.
    Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immuno assay — an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539–544Google Scholar
  14. 14.
    Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in normal serum. J Clin Invest 34: 1345–1353Google Scholar
  15. 15.
    Jacobsen K (1955) Method for the determination of fibrinogen in plasma. Scand J Clin Lab Invest [Suppl.] 14: 14–16Google Scholar
  16. 16.
    Svendsen PAA, Christiansen JS, Søegaard U, Welinder BA, Nerup J (1980) Rapid change in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia 19: 130–136Google Scholar
  17. 17.
    Larsen K (1972) Creatinine assay by a reaction-kinetic principle. Clin Chem Acta 41: 209–217Google Scholar
  18. 18.
    Hanning I, Home PD, Alberti KGMM (1985) Measurements of free insulin concentrations: the influence of timing of extraction of insulin antibodies. Diabetologia 28: 831–835Google Scholar
  19. 19.
    Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebre P, Mathiesen ER, Feldt-Rasmussen B, Schmiitz A, Viberti GC (1985–1986) Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9 (2): 85–95Google Scholar
  20. 20.
    Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF (1981) Hyperlipidaemia in untreateded nephrotic syndrome, increased production or decreased removal? Clin Chim Acta 117: 317–323Google Scholar
  21. 21.
    Ohta T, Matsuda I (1981) Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clin Chem Acta 117: 133–143Google Scholar
  22. 22.
    Felts JM, Mayerle JA (1974) Urinary loss of plasma high density lipoprotein — a possible cause of hyperlipidaemia of the nephrotic syndrome. Circulation 50 [Suppl. 3]: 263Google Scholar
  23. 23.
    Stender S, Hjelms E (1987) In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest 47 [Suppl. 186]: 21–29Google Scholar
  24. 24.
    Renkin EM (1977) Multiple pathways of capillary permeability. Circ Res 4: 735–743Google Scholar
  25. 25.
    Pietri A, Dunn FL, Raskin P (1980) The effect on improved diabetic control on plasma lipid and lipoprotein levels. A comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes 29: 1001–1005Google Scholar
  26. 26.
    Nikkilä EA (1981) High density lipoproteins in diabetes. Diabetes 30 [Suppl. 2]: 82–87Google Scholar
  27. 27.
    Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA 251: 351–374Google Scholar
  28. 28.
    Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttonen JK, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317: 1237–1245Google Scholar
  29. 29.
    Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG (1986) Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park Heart Study. Lancet II: 533–537Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • T. Jensen
    • 1
  • S. Stender
    • 2
  • T. Deckert
    • 1
  1. 1.Steno Memorial HospitalGentofte
  2. 2.Department of Clinical ChemistryKAS GentofteHellerupDenmark

Personalised recommendations